VISTAGEN THERAPEUTICS, INC. Accrued Royalties
VISTAGEN THERAPEUTICS, INC. (VTGN) had Accrued Royalties of $92.10 thousand as of 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities
us-gaap:AccruedRoyaltiesCurrentAndNoncurrent · last filed 2014-06-25
- 2013-09-30: Accrued Royalties $92.10K.
- 2013-03-31: Accrued Royalties $25.00K.
| Period end | Accrued Royalties |
|---|---|
| 2013-09-30 | $92.10K 10-Q · filed 2013-11-14 |
| 2013-03-31 | $25.00K 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |